This inventor holds 1 USPTO granted patent. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Heinrich W Ohlendorf: Innovator in Pharmaceutical Chemistry
Introduction
Heinrich W Ohlendorf is a notable inventor based in Garbsen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the area of diastereoselective reduction processes. His work has implications for the development of new therapeutic agents.
Latest Patents
Ohlendorf holds a patent for a process that involves the diastereoselective reduction of 3-amino-1-benzoxepin-5(2H)-ones. This innovative method allows for the production of cis-2,3,4,5-tetrahydro-3-amino-1-benzoxepin-5-ols through catalytic hydrogenation using a platinum oxide catalyst. The process can also be executed using a borane/amine complex in an aprotic solvent, optionally with a lower aliphatic carboxylic acid. He has 1 patent to his name.
Career Highlights
Ohlendorf is associated with Kali-Chemie Pharma GmbH, where he has been instrumental in advancing pharmaceutical research and development. His expertise in chemical processes has positioned him as a valuable asset in the industry.
Collaborations
He has collaborated with Uwe Maetzel, contributing to various projects that enhance the understanding and application of chemical processes in pharmaceuticals.
Conclusion
Heinrich W Ohlendorf's innovative work in pharmaceutical chemistry exemplifies the impact of targeted research and development in creating effective therapeutic solutions. His contributions continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile